Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · NSE · Updated 15 July 2026

₹1,092.9 ↓ 13.34% (1Y)

🎯 Key Takeaways

Max Healthcare Institute Limited is navigating a phase of strategic consolidation and operational scaling within the healthcare services sector, marked by sustained revenue growth and improving profitability trends. The company emphasizes sustainable growth through ESG integration and patient-centric care, with recent focus on governance and infrastructure alignment.
Revenue grew 9.4% QoQ to ₹1,868 in Q3FY25.
⚠️ Sector-specific demand volatility due to fluctuating patient volumes and healthcare-seeking behavior.

Market Cap

₹1.02 L Cr

P/E Ratio

101.2

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About MAXHEALTH 📊 Interactive Charts

📖 The Story

Max Healthcare Institute Limited is navigating a phase of strategic consolidation and operational scaling within the healthcare services sector, marked by sustained revenue growth and improving profitability trends. The company emphasizes sustainable growth through ESG integration and patient-centric care, with recent focus on governance and infrastructure alignment. Despite a high valuation multiple, its financial trajectory reflects steady operational momentum, though near-term growth may be tempered by macroeconomic and sector-specific headwinds.

📰 What's Happening

In Q3FY25, Max Healthcare reported consolidated revenue of ₹1,868 crore, up from ₹1,707 crore in Q2FY25 and ₹1,543 crore in Q1FY25, indicating consistent top-line expansion. Operating profit rose to ₹459 crore with an OPM of 26.7%, reflecting margin stability amid scale. The company released its FY2025-26 BRSR report on July 8, 2026, underscoring commitments to sustainable healthcare, renewable energy adoption, and waste diversion, though no forward financial guidance was provided. At the AGM scheduled for July 30, 2026, shareholders will vote on re-appointing Mr. Anil Kumar Bhatnagar as Non-Executive Director and approving an increase in his remuneration to ₹40 lakh per annum. The company also plans to shift its registered office from Maharashtra to Haryana to support operational efficiency in North India. These moves signal a focus on governance continuity and regional operational consolidation.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q4FY23	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	1,215	1,285	1,363	1,335	1,423	1,543	1,707	1,868
Operating Profit	381	379	433	432	427	422	491	459
OPM %	28.0%	26.3%	28.4%	28.9%	26.8%	25.1%	26.4%	26.7%
Net Profit	251	240	277	289	252	236	282	239
EPS	₹2.59	₹2.47	₹2.85	₹2.98	₹2.59	₹2.43	₹2.90	₹2.46

The company has demonstrated consistent revenue growth over the past eight quarters, with Q3FY25 revenue reaching ₹1,868 crore, up from ₹1,335 crore in Q3FY24, reflecting expanding patient volumes and service offerings. Operating margins have remained stable around 26-28%, indicating effective cost management despite inflationary pressures. Net profit in Q3FY25 stood at ₹239 crore, slightly down from ₹282 crore in Q2FY25 but in line with seasonal trends, while EPS of ₹2.46 reflects ongoing profitability. The steady improvement in financial metrics aligns with management’s focus on scalable healthcare delivery and operational discipline, as highlighted in recent filings.

🔮 Management Outlook & What's Next

Management has not provided explicit forward financial guidance in recent filings, including the FY2025-26 BRSR report or AGM agenda materials. However, strategic priorities are evident through its focus on ESG integration, operational efficiency, and governance updates. The proposed shift of the registered office to Haryana and re-appointment of key directors suggest an emphasis on stabilizing leadership and aligning corporate structure with operational hubs. Investors should monitor future earnings calls and regulatory filings for any clarification on growth expectations or capital allocation plans.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Healthcare Services

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Apollo Hospitals Enterprise Limited	1.16 L Cr	64.5	20.5%	21.9%	0.64
Max Healthcare Institute Limited	1.02 L Cr	101.2	—	—	—
Fortis Healthcare Limited	72,752	94.6	—	—	—
Aster DM Healthcare Limited	39,048	7.1	—	—	—
Narayana Hrudayalaya Ltd.	37,625	47.7	—	—	—
Global Health Limited	33,405	65.8	—	—	—
Krishna Institute of Medical Sciences Limited	30,477	80.3	—	—	—
Dr. Lal Path Labs Ltd.	26,871	63.6	—	—	—
Syngene International Limited	18,295	36.3	—	—	—
Dr. Agarwal's Health Care Limited	14,266	88.8	14.9%	6.8%	0.13

🔗 Peer Stock Analyses

APOLLOHOSP FORTIS ASTERDM NH MEDANTA

⚠️ Risk Factors

1. Sector-specific demand volatility due to fluctuating patient volumes and healthcare-seeking behavior. 2. Regulatory and compliance risks in a highly governed healthcare environment, including potential changes in insurance reimbursement policies. 3. Execution risks tied to the registered office shift to Haryana, which may impact administrative cohesion if not managed smoothly. 4. ESG-related transition risks, as investments in sustainability initiatives may pressure near-term margins without immediate financial returns.

📋 Recent Filings

🧠 Analyst's Read

Max Healthcare is executing a stable but unspectacular growth trajectory, underpinned by consistent revenue expansion and margin discipline. The lack of forward guidance and modest financial updates suggests management is prioritizing operational consistency over aggressive moves. Investors should watch for clarity on growth drivers beyond volume gains, particularly in specialty services and cost management, as the company navigates a high-valution environment with limited near-term catalysts.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on MAXHEALTH

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXHEALTH — Free

Free account · 2 AI queries/day